These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19639319)

  • 21. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etanercept improved anemia and decreased hepcidin gene expression in a rat model of rheumatoid arthritis.
    Elsheemy MS; Hasanin AH; Mansour A; Mehrez SI; Abdel-Bary M
    Biomed Pharmacother; 2019 Apr; 112():108740. PubMed ID: 30970527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial.
    Doyle MK; Rahman MU; Frederick B; Birbara CA; de Vries D; Toedter G; Wu X; Chen D; Ranganath VK; Westerman ME; Furst DE
    Rheumatology (Oxford); 2013 Jul; 52(7):1214-9. PubMed ID: 23418046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of recombinant human erythropoietin on hepcidin mRNA expression in patients with multiple myeloma].
    Wang FD; Zhou DB; Li SL; Wang X; Zhang JP; Duan MH; Shen T; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):390-4. PubMed ID: 21518494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.
    Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T
    J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.
    Ohsugi Y
    Biol Pharm Bull; 2007 Nov; 30(11):2001-6. PubMed ID: 17978466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.
    Yoshizaki K; Nishimoto N; Mihara M; Kishimoto T
    Springer Semin Immunopathol; 1998; 20(1-2):247-59. PubMed ID: 9836380
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.
    Lepanto MS; Rosa L; Cutone A; Conte MP; Paesano R; Valenti P
    Front Immunol; 2018; 9():2123. PubMed ID: 30298070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters.
    Xu C; Rafique A; Potocky T; Paccaly A; Nolain P; Lu Q; Iglesias-Rodriguez M; St John G; Nivens MC; Kanamaluru V; Fairhurst J; Ishii T; Maldonado R; Choy E; Emery P
    J Clin Pharmacol; 2021 May; 61(5):714-724. PubMed ID: 33314148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autocrine formation of hepcidin induces iron retention in human monocytes.
    Theurl I; Theurl M; Seifert M; Mair S; Nairz M; Rumpold H; Zoller H; Bellmann-Weiler R; Niederegger H; Talasz H; Weiss G
    Blood; 2008 Feb; 111(4):2392-9. PubMed ID: 18073346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.
    Wang JX; Tang W; Zhou R; Wan J; Shi LP; Zhang Y; Yang YF; Li Y; Zuo JP
    Br J Pharmacol; 2008 Mar; 153(6):1303-10. PubMed ID: 18264129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of hepcidin in the anemia of multiple myeloma.
    Sharma S; Nemeth E; Chen YH; Goodnough J; Huston A; Roodman GD; Ganz T; Lichtenstein A
    Clin Cancer Res; 2008 Jun; 14(11):3262-7. PubMed ID: 18519751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using histamine (H1) antagonists, in particular atypical antipsychotics, to treat anemia of chronic disease via interleukin-6 suppression.
    Altschuler EL; Kast RE
    Med Hypotheses; 2005; 65(1):65-7. PubMed ID: 15893120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palladium Nanoplate-Based IL-6 Receptor Antagonists Ameliorate Cancer-Related Anemia and Simultaneously Inhibit Cancer Progression.
    Zhu J; Fu Q; Wang S; Ren L; Feng W; Wei S; Zhang Z; Xu Y; Ganz T; Liu S
    Nano Lett; 2022 Jan; 22(2):751-760. PubMed ID: 35030010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.
    Nishimoto N; Terao K; Mima T; Nakahara H; Takagi N; Kakehi T
    Blood; 2008 Nov; 112(10):3959-64. PubMed ID: 18784373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-22 regulates iron availability in vivo through the induction of hepcidin.
    Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
    J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Humanized anti-human IL-6 receptor antibody, tocilizumab].
    Nishimoto N
    Nihon Rinsho; 2007 Jul; 65(7):1218-25. PubMed ID: 17642235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
    Tanaka T; Narazaki M; Ogata A; Kishimoto T
    Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.
    Nemeth E; Valore EV; Territo M; Schiller G; Lichtenstein A; Ganz T
    Blood; 2003 Apr; 101(7):2461-3. PubMed ID: 12433676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.